The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step BPC 157 Banned: Key Facts on the Latest FDA Decision Gray Market Peptides: So Much Hype, So Little Data FDA Moves to Reevaluate Several Peptides American Med Spa Association